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Abstract: 
Famotidine 40 mg film coated tablet by invitro comparative study , together with the official and non official 
compendial test. Famotidine is an aggressive inhibitor of histamine H2-receptors. The pivotal clinically critical 
pharmacologic activity of Famotidine is to hold of gastric discharge. Both the acid concentration and volume of 
gastric secreation are concealed by famotidine, while changes in pepsin discharge are relative to volume 
generation. Famotidine is more potent than other class of drugs like.the drug is intended to release after oral 
administration for immediate release so we execute testing analysis to illustrate the procedure, the major test for 
analyzing the effectiveness of drug comprises, dissolution , assay, disintegration time, thickness and weight 
variation  in three brands available in market of  Karachi Pakistan. The weight variation test shows outcomes 
within the limits and all brands dissolves within 30 minutes, every brand showed the drug dissolution more than 75 
% within the 30 minutes ,all outcome showed good effectiveness and producing outcomes  within the limits and 
complying the USP recomendation. 
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INTRODUCTION: 
Famotidine was developed by Yamanouchi 
Pharmaceutical Co(1) It was licensed in the mid-80s 
by Merck & Co(2)and is marketed by a organization 
between Merck and Johnson & Johnson. The 
imidazole ring of cimetidine was replaced with a 2-
guanidinothiazole ring. Famotidine proved to be 9 
times extra strong than ranitidine, and 32 times more 
potent than cimetidine.(3) .Famotidine is a viable 
histamine H2-receptor antagonist. Its main 
pharmacodynamic effect in humans is inhibition of 
gastric acid secretion (4) Famotidine is the most 
dominant, specific H2-receptor opponent yet existing 
for ulcer treatment. On a power premise, famotidine 
is roughly multiple times more viable than ranitidine 
and multiple times more compelling than cimetidine. 
Moreover, it expands the gastric mucosal blood 
stream, bringing about an expanded haemostatic 
impact.(5)  FamotidineisN'(aminosulfonyl)-3-[[[2-
[(diaminomethylene)amino]-4-
thiazolyl]methyl]thio]propanimidamide. 
The molecular formula of famotidine is 
C8H15N7O2S3 and its molecular weight is 337.45. 
Famotidine is freely soluble in glacial acetic acid, it  
is a white to pale yellow crystalline compound, 
slightly soluble in methanol, soluble in water very 
faintly, and almost insoluble in ethanol(6) Different 
techniques have been accounted for assessment of 
famotidine, which comprise of spectrophotometric 
strategies, spectrophotometric and 
spectrofluorimetric strategy and investigation by 
stream infusion .In the present correspondence, a 
basic spectrophotometric strategy has been made for 
the evaluation of famotidine from pharmaceutical 
arrangements (7) For  invitro study dissolution tests  
important they have to advocate in vivo study 
situation The use of phosphate buffers which do not 
recount to gastrointestinal lumenal fluids may 
elucidate the summary in vitro-in vivo correlations 
obtained for modified release dosage forms(8) It has 
been uncovered that expanding ionic quality and 
cradle limit of disintegration media builds 
prescription discharge rate.(8) catogries in a few 
pharmaceutical industry, tablet disintegration 
examination is distinctively used to give genuine in 
vitro medication discharge data for both quality 
control purposes, i.e.,solid measurement structure to 
evaluate group to-bunch consistency, for example, 
tablets, and medication advancement, i.e., to 
conjecture profiles fortress in vivo medication 
discharge . (9)(10) For immediate release tablets, The 
drug is proposed to be discharged quickly after 
administration or the tablet is disintegrated in fluid 
before admission and consequently regulated as 
solution(10) Generally the more noteworthy the 
weight connected the harder the tablet., although the 
attributes of granulation have additionally bearing 
hardness .a tablet duarability might be resolved using 
friabilator. For the restorative specialist in the tablet 
to turn out to be completely accessible for retention 
the tablet should initially break down and release the 
medication into the body liquid for disintegration the 
amount fill in the die determine the heaviness of the 
tablet the volume of fill is changed in accordance 
with the initial few of tablets to yield the ideal weight 
and steady. (11) 
Instruments: 
Following are the instruments used for analysis of all 
three brands of  famotidine 40 mg tablet. Electronic 
balance FX 400,Vernier caliper(VC-TY56), 
Disintegration tester 121-L Galvano scientific,GDT-
7L Galvano scientific dissolution tester, p H 
meter(GH-09) and UV – Visible spectrophotometer 
Shimadzu(1800) 
 
MATERIALS AND METHODS: 
For the comparative study of famotidine 40 mg 
tablet, Jinnah  university for women ,provided the 
opportunity to conduct the pharmacopeial test, 
included weight variation test ,disintegration time test 
,assay ,thickness and dissolution test at their research 
lab. All brands were purchased from different 
pharmacies available in Karachi and all the reagents 
were provided by Deajung chemical Korea. 
 
Weight Variation  Test. Most of the pharmacopeia 
include a simple weight test on a specified number of 
tablets, individual weight and the airthmatic mean 
were calculated. The permitted limit of weight 
variation in USP not more than 2 tablets differ from 
the mean by more than 5% and  in B.P the permitted 
limit of weight variation are essentialy the same as 
that of the USP. For performing weight variation test 
select 20 tablets of famotidine 40 mg  and each tablet 
weight were recorded in mg, average weight were 
also noted by using electronic balance. 
Thickness  Test. The thickness test is nonofficial test 
and it could be considerd as an additional control to 
tablet dimension and it increase reproducibility.  
Calibrated vernier caliper were used to determined 
the  thickness of the tablets. Adjusting the ten 
individual tablets, sandwiched between the jaw of 
vernier caliper, record the thickness results in mm.  
Disintegration Time. The disintegration test is 
useful as a quality assurance tool for conventional 
dosage forms. The disintegration test is carried out by 
using disintegration tester which was consist of a 
basket rack holding 6 tubes, open at the top and 
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bottom, the bottom of the tube was covered by 40 
mesh screen, the basket was  immersed in a bath of 
suitable liquid held at 37 oC preferably in a 1 liter 
beaker. By  using disintegration tester  6 tablets were 
placed in tubes containing baskets and cover it with 
discs and  disintegration time were determined by 
visualizing each tablet to break and completely 
dissolved, showing the time in sec or minutes.  
Pharmaceutical Assay. Spectrophotometer is 
suitable for measuring the ultravoilet and visible 
range of the spectrum. Following are analytical 
testing method of the famotidine 40 mg tablet by UV-
Visible spectrophotometer 1800 UV-VIS (shimadzu). 
 
Diluent Preparation  
Methanol            : 400 ml 
Distilled water    : 600 ml 
Phosphoric acid : 2 ml 
Mixed the above solution and adjusted pH to 5.0 
either by NaOH or by Phosphoric acid.  
 
Standard Preparation 
Weigh accurately 0.0500 gm of Famotidine  standard 
in 50 ml volumetric flask. Dissolved in diluent and 
maked up the volume with diluent. Dilute 2 ml of the 
above solution to 100ml volumetric flask and filled 
up the volume with diluent and shaked well. 
 
Sample Preparation  
Accurately weighed the 20 tablets powder equivalent 
to Famotidine standard and shift into 50 ml 
volumetric flask include about 30 ml of diluent and 
sonicate for about 30 minutes. After 30 minutes 
maked up the volume with diluent and shaked well. 
Filtered the above solution through whatman # 1 
filter paper. Dilute 2 ml of the above filtrate to 100 
ml volumetric flask and filled up the volume with 
diluent and shaked well .Measured the absorbance of 
both standard and sample preparation on a suitable 
spectrophotometer at 265 nm using diluent as blank.  
 
Calculations 
Calculate the content of Famotidine per tablet by 
using following equation. 
 
                             
 
Where, 
 
Asp              = Absorbance due to Famotidine in sample preparation.  
Astd             = Absorbance due to Famotidine in standard preparation. 
Sw               = Standard weight. 
Sp.wt.          = Sample weight. 
P                  = Purity of standard. 
 
Dissolution Test. Dissolution tester GDT-7L 
Galvano scientific used for the comparative study of 
famotidine 40 mg tablet. Tablet dissolution is a 
standardized method for measuring the rate of drug 
release from a dosage form. The principle function of 
the dissolution test is to optimization of therapeutic 
effectiveness during product development and 
stability assessment and routine assessment of 
production quality to ensure uniformity between 
products lots. 
 
Dissolution Condition    
APPARATUS USP II (PADDLE) 
RPM    50 
TIME 30 MINUTES 
LIMIT NLT 75 % 
 
Dissolution Medium  
pH 4.5,0.1M potassium phosphate buffer. Prepared 
by dissolving 13.6 gm of monobasic potassium 
phosphate (Potassium dihydrogen phosphate) in one 
liter of water. 
 
 
 
Standard Preparation  
Weigh accurately 0.0440 g of Famotidine standard in 
100 ml of volumetric flask and dissolved in 
dissolution medium. Pipette 10ml of the above 
solution into 100 ml volumetric flask and dilute the 
volume with dissolution medium and shaked well. 
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Sample Preparation 
Place one tablet each in 6 dissolution flask containing 
900 ml of dissolution medium, previously adjusted to 
37ºC ± 0.5ºC. Immediately operate the apparatus. At 
the specified time, withdraw the sample from a zone 
midway after min,30 min between the surface of 
medium and top of the rotating blade not less than 1 
cm from vessel wall. Filtered the sample, evaluated 
the absorbance of standard and sample preparation on 
a appropriate spectrophotometer at the wavelength of 
265 nm using dissolution medium as a blank. 
Calculated the amount of Famotidine dissolved in 
specified time by using following equation. 
 
Asp  x Sw  x  10  x  900  x P   =       %  dissolved. 
Astd x 100 x 100 x  Sp. 
 
Where, 
Asp     = Absorbance of sample due to famotidine. 
Astd    = Absorbance of standard due to famotidine. 
Sw      = Standard weight. 
Sp      = Tablet sample. 
P        = Purity of standard. 
 
RESULTS: 
The comparative study of Famotidine 40 mg Tablet 
showed all the results within the limits and following 
USP. Physicochemical analysis of three different 
brands of Famotidine 40 mg tablet followed the 
weight variation test, disintegration test ,thickness 
,diameter, dissolution on single point and assay. 
Results of weight variation/average weight for  Fam-
01 was 234.2 mg with (260.127 – 208.272 mg) upper 
and lower limits,for Fam -2 average weight was 
309.5 mg with (356.9 – 262.09 mg) upper and lower 
limits,for Fam -3 average weight was 201.7 mg 
with(231.077-172.323mg) upper and lower limits 
shown in table 02.The results of thickness 
variation(mm) of Fam- 01 was 4.17 mm with(4.3 – 
3.9mm ) upper and lower limits, Fam-02 was 4.7 mm 
with (4.8 – 4.5 mm) upper and lower limits, Fam – 03 
was 4.25 mm with (4.85 – 4.01 mm) upper and lower 
limits shown in table 03. The results of diameter 
variation of Fam – 01 was 8.83 mm with (9.0 – 8.58 
mm) upper and lower limits, Fam – 02 was 9.35 mm 
with (9.9 – 8.7 mm ) upper and lower limits, Fam – 
03 was 8.7 mm with (8.89 – 8.50 mm) upper and 
lower limits shown in table 04.The disintegration test 
showing results for Fam – 01 was 3 minutes, Fam-02 
is 5 minutes,Fam – 03 was 5 minutes with the 
BP/USP limit(NMT 30 minutes) shown in table 05, 
The Dissolution test showing the results within the 
limits. Results for Fam – 01 was 98 %, Fam – 02 was 
104.5 %, Fam – 03 is 99.23 % with USP limit NLT 
75 % shown in table 6, The results for Assay percent 
test for Fam -01 is 99.41 % ,Fam-02 was 99.42 % 
and Fam -03 was 98.08 % with USP limit (90 – 110 
%) shown in table 7.. 
DISCUSSION: 
The main objective of this research work was to 
evaluate and compared  the effectiveness of  the three 
different brands of famotidine 40 mg tablet  available 
in local  markets of Karachi. According to the 
BP/USP limits evaluation of physical and chemical 
test like weight variation test ,thickness, diameter 
disintegration ,dissolution and assay percent test were 
showing results within their specified upper and 
lower limit  of 7.5%.There is no official limits of 
thickness and diameter but all brands of famotidine 
40 mg tablet  were having similar thickness and 
diameter within the brands. And disintegration time 
were also found within the limits of BP/USP ,  brand 
Fam-01 were dissolved within 3 minutes as compare 
to the other brands which were took 5 minutes to 
dissolved.US Pharmacopeial limits of dissolution test 
is NLT 75 % in 30 minutes and all  brands of 
famotidine 40 mg tablet dissolved within time but 
Fam - 02 have shown the excellent results as 
compared to other brands. assay percent limits of 
famotidine 40 mg tablet according to the USP have 
90 – 110%  and all brands were found within the 
limits. 
 
CONCLUSION: 
It was concluded from the results of famotidine 40 
mg tablet that all brands showing minor variation in 
there invitro quality control test but these variation 
were found under the specified limits of USP/BP, so 
quality standards of all three brands are same but  
there is a difference in there packaging and there 
MRP’s. 
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Table 1 : Specifications  of famotidine tablets 40 mg different Brands 
NO Brand Name Serial number Code Number Batch number 
1 Nocid Fam-1 018064 J0022 
2 Bessfam Fam-2 047460 009 
3 Famosure Fam-3 029249 025 
 
Table 2 : Statistical weight Variation test of famotidine tablets 40 mg 
No Serial 
number 
Batch 
number 
Average 
weight (x)mg 
U.S.P 
Standard 
deviation 
(S) 
Upper Limit 
U.S.P 
(UCL=X+ 7.5 S) 
Lower Limit 
U.S.P 
(LCL=X+-7.5 S) 
1 Fam-1 J0022 234.2 3.457 260.127 208.272 
2 Fam-2 009 309.5 6.321 356.9 262.092 
3 Fam-3 025 201.7 3.917 231.077 172.323 
 
Table :3  Statistical thickness Variation test of famotidine tablets 40 mg 
No Serial 
number 
Batch 
number 
Average 
thickness 
(mm) 
 
Standard 
deviation 
(S) 
Upper 
Limit 
(UCL=X+ 
3S) 
Lower 
Limit 
(LCL=X+-
3 S) 
1 Fam-1 J0022 4.17 0.068 4.374 3.966 
2 Fam-2 009 4.7 0.048 4.844 4.556 
3 Fam-3 025 4.25 0.078 4.484 4.016 
 
Table :4  Statistical diameterVariation test of famotidine tablets 40 mg 
No Serial 
number 
Batch 
number 
Average 
diameter 
(mm) 
 
Standard 
deviation 
(S) 
Upper 
Limit 
(UCL=X+ 
3S) 
Lower 
Limit 
(LCL=X+-
3 S) 
1 Fam-1 J0022 8.83 0.0823 9.076 8.581 
2 Fam-2 009 9.35 0.187 9.911 8.789 
3 Fam-3 025 8.7 0.066 8.898 8.502 
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Table :5  Disintegration test of famotidine tablets 40 mg 
Serial 
number 
Code 
Number 
Batch 
number 
Disintegration 
Time  Result 
(min) 
B.P/USP 
Spec. 
Deviation 
From 
BP/USP 
Fam-1 018064 J0022 3 min NMT 30 min Pass 
Fam-2 047460 009 5 min NMT 30 min Pass 
Fam-3 029249 025 5 min NMT 30 min Pass 
 
Table :6  Dissolution test of famotidine tablets 40 mg 
Serial 
number 
Code 
Number 
Batch 
number 
Dissolution 
test Result 
(%) 
USP 
Spec. 
Deviation 
From 
Official limit 
Fam-1 018064 J0022 98.0 NLT 75% Pass 
Fam-2 047460 009 104.5 NLT 75% Pass 
Fam-3 029249 025 99.23 NLT 75% Pass 
 
Table :7 Assay percent  test of famotidine tablets 40 mg 
Serial 
number 
Code 
Number 
Batch 
number 
Assay percent 
test Result 
(%) 
USP 
Spec. 
Deviation 
From 
Official limit 
Fam-1 018064 J0022 99.41 90 -110% Pass 
Fam-2 047460 009 99.42 90 -110% Pass 
Fam-3 029249 025 98.98 90 -110% Pass 
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